Farther Finance Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.26M | Buy |
39,100
+4,908
| +14% | +$911K | 0.15% | 130 |
|
2025
Q1 | $7.05M | Buy |
34,192
+11,387
| +50% | +$2.35M | 0.18% | 114 |
|
2024
Q4 | $4.05M | Sell |
22,805
-458
| -2% | -$81.4K | 0.15% | 128 |
|
2024
Q3 | $4.59M | Buy |
23,263
+3,542
| +18% | +$699K | 0.17% | 104 |
|
2024
Q2 | $3.36M | Buy |
19,721
+1,409
| +8% | +$240K | 0.16% | 108 |
|
2024
Q1 | $3.31M | Buy |
18,312
+1,461
| +9% | +$264K | 0.2% | 94 |
|
2023
Q4 | $2.61M | Buy |
16,851
+11,017
| +189% | +$1.71M | 0.19% | 102 |
|
2023
Q3 | $870K | Buy |
5,834
+941
| +19% | +$140K | 0.14% | 132 |
|
2023
Q2 | $659K | Buy |
4,893
+905
| +23% | +$122K | 0.14% | 131 |
|
2023
Q1 | $636K | Buy |
3,988
+1,239
| +45% | +$197K | 0.19% | 103 |
|
2022
Q4 | $444K | Buy |
+2,749
| New | +$444K | 0.17% | 118 |
|